investment

News

Gilde’s new investment fund reaches €740m at close

Netherlands-based investment group Gilde Healthcare has finally closed its new Venture & Growth VI fund with committed funding of €740 million, well ahead of its origi

R&D

While diabetes & obesity fund Novo Nordisk, its Foundation f...

The Novo Nordisk Foundation is not a charitable organisation owned by the pharma company Novo Nordisk. In fact, it’s the other way around, more or less.

News

Activist investor Elliott turns its attention to BioMarin

Hedge Fund Elliott Management has bought a big stake in BioMarin Pharma, causing a spike in the company’s share price, and started discussions with the company about its s

Digital

How over-investment is killing digital health companies

The future of public health is set to become increasingly digital, with technological advancements enabling healthcare players to provide more targeted and effective interventions to patien

R&D

Attracting investors takes more than good science

Scientists in the C-Suite: Attracting investors takes more t...

In the ever-evolving landscape of the biotechnology sector, the ability to attract investors effectively stands as the decisive factor that separates the success of your pioneering research

News

MSD gives warning to UK ahead of $1.3bn facility work

In 2017, MSD made the decision to open a $1.32 billion, 220,000 sq ft research facility in the heart of London’s ‘knowledge quarter’ around King’s Cross.

Gilde’s new investment fund reaches €740m at close

While diabetes & obesity fund Novo Nordisk, its Foundation f...

Activist investor Elliott turns its attention to BioMarin

How over-investment is killing digital health companies

Scientists in the C-Suite: Attracting investors takes more t...

MSD gives warning to UK ahead of $1.3bn facility work

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

investment

Editor's Picks